Washington D.C. [USA], June 17 (ANI): Infectious disease experts are advocating for earlier actions to reduce hospitalizations and deaths from COVID-19.
Haridwar (Uttarakhand) [India], June 13 (ANI): Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, on Saturday, claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 5-14 days.
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new drug for only 'compassionate Use' for treatment of patients by hospitals or medical institutions under New Drugs and Clinical Trials Rules, 2019.
New Delhi [India], June 6 (ANI): Clinical trials of the plant-derived drug, ACQH, to treat COVID-19 patients that began on Friday in India has been hailed by the Council of Scientific and Industrial Research (CSIR) as "historic in modern medicine".
Washington D.C. [USA], May 31 (ANI): The findings of a recent study show that over the past decade -- women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enr
Washington D.C. [USA], May 28 (ANI): Over the past decade, women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrolment numbers, finds a recent study.
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
New Delhi [India], May 26 (ANI): Health Ministry of India has written to the World Health Organisation (WHO) after the global health body announced to temporarily suspend the clinical trials of Hydroxychloroquine (HCQ) for the treatment of COVID-19 patients, sources told ANI.
Washington D.C. [USA], May 17 (ANI): Clinical trials of the anti-malarial drug or hydroxychloroquine, which gained prominence overnight after being promoted by US President Donald Trump as a 'game changer' in the fight against Covid-19, have been significantly linked to cardiac problems and
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.